Aatmaj Healthcare Limited has announced its standalone audited financial results for the financial year ended March 31, 2026. The Board of Directors approved the results during a meeting held on May 14, 2026. The company reported a rise in both revenue and profitability for the fiscal year.

Financial Performance

For the year ended March 31, 2026, the company reported a net profit of ₹71.34 lakh, compared to ₹63.92 lakh in the previous year. Revenue from operations increased to ₹2,431.80 lakh from ₹1,953.34 lakh in the prior year. Total revenue for the period stood at ₹2,527.33 lakh.

The company’s total expenses for the year amounted to ₹2,430.39 lakh, up from ₹1,977.94 lakh in the previous year. Profit before tax for the year was ₹96.94 lakh, slightly lower than the ₹107.07 lakh recorded in the preceding year.

Key Metrics

The basic and diluted earnings per equity share for the year stood at ₹0.32, compared to ₹0.28 in the previous year. The paid-up equity share capital remained constant at ₹1,130.00 lakh, with a face value of ₹5 per share.

The following table summarizes the financial performance for the year:

IPO Proceeds Utilization

The company provided details regarding the utilization of its Initial Public Offering (IPO) proceeds up to March 31, 2026. The total amount utilized was ₹3,840.00 lakh, which included funds allocated for repayment of debt, working capital requirements, purchase of medical equipment, inorganic growth initiatives, general corporate expenses, and issue expenses. The statutory auditors confirmed that there is no amount pending to be utilized from the IPO proceeds as of March 31, 2026.

Balance Sheet Highlights

As of March 31, 2026, the company’s total assets stood at ₹7,664.56 lakh, compared to ₹6,325.06 lakh in the previous year. Shareholders' funds, comprising share capital and reserves, increased to ₹5,083.47 lakh from ₹5,012.15 lakh. Non-current liabilities included long-term borrowings of ₹879.71 lakh, while current liabilities included short-term borrowings of ₹1,223.51 lakh.

Aatmaj Healthcare Limited, a Vadodara-based multi-speciality hospital operator listed on the NSE Emerge platform, approved its standalone audited financial results for the year ended March 31, 2026, at a Board of Directors meeting held on May 14, 2026. The results, reviewed by the Audit Committee and audited by Bela Mehta and Associates, Chartered Accountants, received an unmodified audit opinion. The company operates primarily in the business of running multi-speciality hospitals, with all operations based in India.

Financial Performance: FY26 vs FY25

Aatmaj Healthcare recorded steady growth in revenue and profitability for the full year ended March 31, 2026. Revenue from operations increased to ₹2,431.80 lakhs from ₹1,953.34 lakhs in the previous year, while other income stood at ₹95.53 lakhs compared to ₹131.67 lakhs in FY25. Total revenue for FY26 came in at ₹2,527.33 lakhs against ₹2,085.01 lakhs in FY25. Net profit for the year rose to ₹71.34 lakhs from ₹63.92 lakhs in the prior year.

The following table summarises the key financial metrics for the full year:

Half-Year Performance Breakdown

For the six months ended March 31, 2026, the company reported total revenue of ₹1,402.32 lakhs and a net profit of ₹19.84 lakhs. This compares to total revenue of ₹1,125.01 lakhs and net profit of ₹51.07 lakhs for the six months ended September 30, 2025, and total revenue of ₹1,158.49 lakhs with net profit of ₹33.29 lakhs for the six months ended March 31, 2025. The face value of each equity share remained at ₹5 across all periods.

Balance Sheet and Key Ratios

As at March 31, 2026, total assets stood at ₹7,664.56 lakhs compared to ₹6,325.06 lakhs as at March 31, 2025. Shareholders' funds comprised share capital of ₹1,130.00 lakhs and reserves and surplus of ₹3,953.47 lakhs. Long-term borrowings increased to ₹879.71 lakhs from ₹156.09 lakhs, while short-term borrowings rose to ₹1,223.51 lakhs from ₹850.22 lakhs. Cash and cash equivalents at the end of the period were ₹1,169.50 lakhs, compared to ₹1,216.23 lakhs at the beginning of the period.

Key financial ratios for FY26 compared to FY25 are presented below:

IPO Proceeds: Full Utilisation Confirmed

The company confirmed complete utilisation of its IPO proceeds totalling ₹3,840.00 lakhs as on March 31, 2026. The equity shares of Aatmaj Healthcare have been listed on the NSE Emerge platform with effect from June 30, 2023. The utilisation details, as verified by the statutory auditors, are as follows:

It is noted that the Board of Directors sought and received member approval by way of Special Resolution dated May 27, 2025, for variation in the objects of the prospectus dated June 13, 2023, permitting the utilisation of IPO proceeds amounting to ₹913.11 lakhs for the purchase of medical equipment in lieu of working capital requirements. The Special Resolution was approved by members through remote e-voting, which concluded on June 28, 2025, with a scrutiniser's report submitted to NSE on the same date. As on March 31, 2026, there is nil amount pending to be utilised from the IPO proceeds.